126 related articles for article (PubMed ID: 19073182)
1. Minor group human rhinovirus-receptor interactions: geometry of multimodular attachment and basis of recognition.
Querol-Audí J; Konecsni T; Pous J; Carugo O; Fita I; Verdaguer N; Blaas D
FEBS Lett; 2009 Jan; 583(1):235-40. PubMed ID: 19073182
[TBL] [Abstract][Full Text] [Related]
2. X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein.
Verdaguer N; Fita I; Reithmayer M; Moser R; Blaas D
Nat Struct Mol Biol; 2004 May; 11(5):429-34. PubMed ID: 15064754
[TBL] [Abstract][Full Text] [Related]
3. Expression and folding of human very-low-density lipoprotein receptor fragments: neutralization capacity toward human rhinovirus HRV2.
Ronacher B; Marlovits TC; Moser R; Blaas D
Virology; 2000 Dec; 278(2):541-50. PubMed ID: 11118376
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the first ligand-binding repeat of the human very-low-density lipoprotein receptor results in high-affinity binding of the single V1 module to human rhinovirus 2.
Nizet S; Wruss J; Landstetter N; Snyers L; Blaas D
J Virol; 2005 Dec; 79(23):14730-6. PubMed ID: 16282473
[TBL] [Abstract][Full Text] [Related]
5. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of a common cold virus by concatemers of the third ligand binding module of the VLDL-receptor strongly depends on the number of modules.
Moser R; Snyers L; Wruss J; Angulo J; Peters H; Peters T; Blaas D
Virology; 2005 Aug; 338(2):259-69. PubMed ID: 15950998
[TBL] [Abstract][Full Text] [Related]
7. Mimicking early events of virus infection: capillary electrophoretic analysis of virus attachment to receptor-decorated liposomes.
Bilek G; Kremser L; Wruss J; Blaas D; Kenndler E
Anal Chem; 2007 Feb; 79(4):1620-5. PubMed ID: 17297964
[TBL] [Abstract][Full Text] [Related]
8. Twelve receptor molecules attach per viral particle of human rhinovirus serotype 2 via multiple modules.
Konecsni T; Kremser L; Snyers L; Rankl C; Kilár F; Kenndler E; Blaas D
FEBS Lett; 2004 Jun; 568(1-3):99-104. PubMed ID: 15196928
[TBL] [Abstract][Full Text] [Related]
9. Predictive bioinformatic identification of minor receptor group human rhinoviruses.
Weber C; Pickl-Herk A; Khan AG; Strauss S; Carugo O; Blaas D
FEBS Lett; 2009 Aug; 583(15):2547-51. PubMed ID: 19615999
[TBL] [Abstract][Full Text] [Related]
10. Attachment of VLDL receptors to an icosahedral virus along the 5-fold symmetry axis: multiple binding modes evidenced by fluorescence correlation spectroscopy.
Wruss J; Rünzler D; Steiger C; Chiba P; Köhler G; Blaas D
Biochemistry; 2007 May; 46(21):6331-9. PubMed ID: 17472347
[TBL] [Abstract][Full Text] [Related]
11. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.
Hewat EA; Neumann E; Conway JF; Moser R; Ronacher B; Marlovits TC; Blaas D
EMBO J; 2000 Dec; 19(23):6317-25. PubMed ID: 11101504
[TBL] [Abstract][Full Text] [Related]
12. Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras.
Herdy B; Snyers L; Reithmayer M; Hinterdorfer P; Blaas D
J Virol; 2004 Jul; 78(13):6766-74. PubMed ID: 15194751
[TBL] [Abstract][Full Text] [Related]
13. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding.
Vlasak M; Roivainen M; Reithmayer M; Goesler I; Laine P; Snyers L; Hovi T; Blaas D
J Virol; 2005 Jun; 79(12):7389-95. PubMed ID: 15919894
[TBL] [Abstract][Full Text] [Related]
14. Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.
Reischl A; Reithmayer M; Winsauer G; Moser R; Gösler I; Blaas D
J Virol; 2001 Oct; 75(19):9312-9. PubMed ID: 11533194
[TBL] [Abstract][Full Text] [Related]
15. Conformation of receptor adopted upon interaction with virus revealed by site-specific fluorescence quenchers and FRET analysis.
Wruss J; Pollheimer PD; Meindl I; Reichel A; Schulze K; Schöfberger W; Piehler J; Tampé R; Blaas D; Gruber HJ
J Am Chem Soc; 2009 Apr; 131(15):5478-82. PubMed ID: 19331321
[TBL] [Abstract][Full Text] [Related]
16. Rhinovirus-stabilizing activity of artificial VLDL-receptor variants defines a new mechanism for virus neutralization by soluble receptors.
Nicodemou A; Petsch M; Konecsni T; Kremser L; Kenndler E; Casasnovas JM; Blaas D
FEBS Lett; 2005 Oct; 579(25):5507-11. PubMed ID: 16213497
[TBL] [Abstract][Full Text] [Related]
17. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.
Kolatkar PR; Bella J; Olson NH; Bator CM; Baker TS; Rossmann MG
EMBO J; 1999 Nov; 18(22):6249-59. PubMed ID: 10562537
[TBL] [Abstract][Full Text] [Related]
18. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination.
Vlasak M; Blomqvist S; Hovi T; Hewat E; Blaas D
J Virol; 2003 Jun; 77(12):6923-30. PubMed ID: 12768011
[TBL] [Abstract][Full Text] [Related]
19. Recombinant soluble low-density lipoprotein receptor fragment inhibits common cold infection.
Marlovits TC; Zechmeister T; Schwihla H; Ronacher B; Blaas D
J Mol Recognit; 1998; 11(1-6):49-51. PubMed ID: 10076805
[TBL] [Abstract][Full Text] [Related]
20. A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid.
Neumann E; Moser R; Snyers L; Blaas D; Hewat EA
J Virol; 2003 Aug; 77(15):8504-11. PubMed ID: 12857919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
